MoneyWorks4Me

Novelix Pharmaceuticals informs about disclosure

02 Jun 2026 Evaluate
Novelix Pharmaceuticals has informed that the exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of shares & Takeovers) Regulations, 2011 for Srindhi Fine Chemicals LLP.

The above information is a part of company’s filings submitted to BSE. 


Peers